معرفی
Professor Ahmed Ahmed is a Professor of Gynaecological Oncology at the University of Oxford's Nuffield Department of Women's & Reproductive Health and a Consultant Gynaecological Oncology Surgeon at the Oxford Cancer and Haematology Centre. He is a Fellow of St Hugh's College and serves as Director of the Ovarian Cancer Cell Laboratory at the Weatherall Institute of Molecular Medicine. His research focuses on understanding the fundamental mechanisms of ovarian cancer development and progression, with particular emphasis on identifying the cell of origin for ovarian cancer.
Professor Ahmed graduated from Ain Shams University in Cairo, Egypt and completed his PhD and Gynaecological Oncology Surgical training at the University of Cambridge. He received additional postdoctoral research training at both the University of Cambridge and the University of Texas, M.D. Anderson Cancer Centre in the USA. He was appointed as a Clinical Reader in Oxford in 2010 and became a Medical Research Council Senior Clinical Research Fellow at the Weatherall Institute of Molecular Medicine and Professor of Gynaecological Oncology in 2012.
His research program centers on translational gynaecological oncology, with major focus areas including:
- Identifying the cell of origin for ovarian cancer through single-cell sequencing of normal fallopian tube epithelial cells
- Developing 3D microtumor models representing ovarian cancer minimal residual disease
- Investigating metabolic pathways in ovarian cancer, particularly fatty acid oxidation
- Exploring molecular heterogeneity in ovarian cancer through advanced genomic and transcriptomic analyses
- Developing risk stratification models for guiding treatment decisions
Professor Ahmed's publication record demonstrates a consistent trajectory of high-impact research in ovarian cancer biology. His recent work (2021-2025) shows increasing sophistication in methodologies, moving from basic molecular characterization to developing advanced computational and 3D modeling approaches. A notable theme across his publications is the focus on the fallopian tube as the likely origin of high-grade serous ovarian cancer, with multiple papers exploring stem cell populations and early tumorigenic events in this tissue. His team has also made significant contributions to understanding minimal residual disease and developing models for drug screening.
Professor Ahmed leads an active research group with multiple postdoctoral researchers and students. His laboratory is part of the broader collaborative network at the MRC Weatherall Institute of Molecular Medicine, with connections to Ovarian Cancer Action, Target Ovarian Cancer, CRUK Oxford Cancer Research Centre, and the NIHR Oxford Biomedical Research Centre. His team has developed specialized 3D microtumor systems that faithfully represent ovarian cancer minimal residual disease, which has significant implications for developing new therapeutic approaches to prevent cancer recurrence.
